SEARCH CONTACT US

ACCESSIBILITY

24/7

Headlines

French New (tech) Wave: The country’s foray into high-tech is cementing Macron’s legacy

NimBio unveils AI-powered Inflammometer to predict IBD flares before they strike

Full list of Israeli high-tech funding rounds in 2025

Hirundo raises $8M in Seed funding to help AI forget its mistakes

Buzz

Most popular

Daily

Weekly

1

Once a $400M prospect, Autotalks sold to Qualcomm for less than $100M

2

Carbyne raising $100M in AT&T-led round to expand its app-free 911 platform

3

Intel Products CEO: “Employees are very optimistic about the fact that Lip-Bu can help us”

4

Michael Levitt Analysis: Corona Is Slowing Down, Humanity Will Survive

5

AI cuts begin at the bottom: Entry-level jobs disappear in the age of automation

IOPtima

2 stories about IOPtima

BioLight ביולייט איי אופטימה IOPtima

Chengdu Kanghong Pharma Solidifies Ownership of Israeli Medical Device Company

27.09.18|Lilach Baumer

The company paid $7 million in 2017 for 19% of IOPtima, a developer of minimally invasive devices for eye surgery

BioLight ביולייט איי אופטימה IOPtima

Shenzhen-listed Pharma Company to Acquire Tel Aviv-based Medtech Company IOPtima

21.11.17|Lilach Baumer

The Chengdu Kanghong Pharma Group will buy Tel Aviv-based IOPtima in four stages, the latter announced Tuesday through its parent company listed on the Tel Aviv Stock Exchange